OSL oncosil medical ltd

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-10

  1. 6,553 Posts.
    lightbulb Created with Sketch. 252
    Estimated cash position by end Dec 2022 - see below

    Cash end Sep 7.95 m
    RD Refund Oct .83m
    Est. sales to end Oct to Dec. .75m

    Est total. 9.53 m

    less current Q cash burn Oct to Dec est. 3 m

    end of Dec. Cash availb est 6.53

    that leads me to think that a CR won’t be coming this quarter, but rather possibly in Feb or March

    if by then, you have FDA approval or sales in Germany. I would think we will have a direct placement by a fund or something similar at 10c .
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.01
Change
-0.025(2.43%)
Mkt cap ! $14.29M
Open High Low Value Volume
$1.04 $1.05 $1.00 $41.05K 40.86K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.01
 

Sellers (Offers)

Price($) Vol. No.
$1.05 1249 1
View Market Depth
Last trade - 15.47pm 20/06/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.